JPH0349690A - Preparation of l-glutamic acid - Google Patents
Preparation of l-glutamic acidInfo
- Publication number
- JPH0349690A JPH0349690A JP1186282A JP18628289A JPH0349690A JP H0349690 A JPH0349690 A JP H0349690A JP 1186282 A JP1186282 A JP 1186282A JP 18628289 A JP18628289 A JP 18628289A JP H0349690 A JPH0349690 A JP H0349690A
- Authority
- JP
- Japan
- Prior art keywords
- glutamic acid
- brevibacterium
- microorganism
- prepare
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 title claims abstract description 29
- 229960002989 glutamic acid Drugs 0.000 title claims abstract description 15
- 241000186146 Brevibacterium Species 0.000 claims abstract description 7
- 241000186216 Corynebacterium Species 0.000 claims abstract description 5
- 244000005700 microbiome Species 0.000 claims abstract description 5
- 238000012258 culturing Methods 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract description 5
- 229960002685 biotin Drugs 0.000 abstract description 4
- 235000020958 biotin Nutrition 0.000 abstract description 4
- 239000011616 biotin Substances 0.000 abstract description 4
- 239000004202 carbamide Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract description 2
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003456 ion exchange resin Substances 0.000 abstract description 2
- 229920003303 ion-exchange polymer Polymers 0.000 abstract description 2
- 230000035772 mutation Effects 0.000 abstract description 2
- 239000002699 waste material Substances 0.000 abstract description 2
- 241000186226 Corynebacterium glutamicum Species 0.000 abstract 2
- BWDOCCNJZQOHQF-GYENTSQJSA-N (2r)-2-amino-n-(4-amino-1,3-dihydroxy-5-oxopentan-2-yl)propanamide;hydrochloride Chemical compound [Cl-].C[C@@H]([NH3+])C(=O)NC(CO)C(O)C(N)C=O BWDOCCNJZQOHQF-GYENTSQJSA-N 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- XZCFXWQEALCPOV-UHFFFAOYSA-N Prumyciin Natural products CC(N)C(=O)NC1COC(O)C(N)C1O XZCFXWQEALCPOV-UHFFFAOYSA-N 0.000 abstract 1
- WNHRQLPCWMCOQE-UHFFFAOYSA-N Prumycin Natural products CC(N)C(=O)NCC1OC(O)C(N)C1O WNHRQLPCWMCOQE-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BQQVEASFNMRTBA-UHFFFAOYSA-N 2-[4-(3-aminopropyl)piperazin-1-yl]ethanol Chemical compound NCCCN1CCN(CCO)CC1 BQQVEASFNMRTBA-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 1
- 241000807905 Corynebacterium glutamicum ATCC 14067 Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 150000008539 L-glutamic acids Chemical class 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- GUAFOGOEJLSQBT-UHFFFAOYSA-N aesculetin dimethyl ether Natural products C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- IRZRPCGCUMAJRH-UHFFFAOYSA-L calcium;urea;carbonate Chemical compound [Ca+2].NC(N)=O.[O-]C([O-])=O IRZRPCGCUMAJRH-UHFFFAOYSA-L 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- -1 thiamine and biotin Chemical class 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- WTHDKMILWLGDKL-UHFFFAOYSA-N urea;hydrate Chemical compound O.NC(N)=O WTHDKMILWLGDKL-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/14—Glutamic acid; Glutamine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
L−グルタミン酸は調味料及びアミノ酸輸液原料等の重
要なアミノ酸であり、本発明はこのLーグルタミン酸を
発酵法で製造する方法を改良するものである.
〔従来技術〕
ブレビバクテリウム属又はコリネバクテリウム属の野性
株又は、グルタミン酸アナログ耐性株、ケトマロン酸及
びフルオロ酢酸等の呼吸阻害剤耐性株、エスクレチン耐
性株等を使用する方法が知られている。[Detailed Description of the Invention] [Industrial Application Field] L-glutamic acid is an important amino acid for seasonings and raw materials for amino acid infusions, and the present invention improves the method for producing this L-glutamic acid by fermentation. It is. [Prior Art] Methods using wild strains of the genus Brevibacterium or Corynebacterium, strains resistant to glutamic acid analogs, strains resistant to respiratory inhibitors such as ketomalonic acid and fluoroacetic acid, strains resistant to esculetin, etc. are known.
(発明が解決しようとする問題点〕
L−グルタミン酸の製造コストを低下させるために発酵
収率を向上させることにある。(Problems to be Solved by the Invention) An object of the present invention is to improve the fermentation yield in order to reduce the manufacturing cost of L-glutamic acid.
本発明は上記問題点を解決するためになされたものであ
り、従来よりL−グルタミン酸の生産菌として知゛られ
るブレビバクテリウム属またはコリネバクテリウム属に
属する微生物に、プルマイシン又はその誘導体に耐性を
有する変異株を育種すると、L−グルタミン酸の収率が
向上する事を見出した。プルマイシンは、バチルス属細
菌が産生,する抗生物質として知られている。The present invention was made to solve the above-mentioned problems, and it has been made to make microorganisms belonging to the genus Brevibacterium or Corynebacterium, which are conventionally known as L-glutamic acid producing bacteria, resistant to purmycin or derivatives thereof. It has been found that the yield of L-glutamic acid is improved by breeding a mutant strain having the following. Purmycin is known as an antibiotic produced by bacteria of the genus Bacillus.
本発明に使用するブレビバクテリウム属またはコリネバ
クテリウム属のプルマイシン、およびその誘導体に耐性
を有する菌株は、例えば以下の菌株がある。Examples of strains of the genus Brevibacterium or Corynebacterium that are resistant to purmycin and derivatives thereof used in the present invention include the following strains.
うY
AJ 1247B (FERM−
これらの菌株は、それぞれブレビバクテリウム・ラクト
フェルメンタム^TCC 13869、ブレビバクテリ
ウム・フラバムATCC 14067およびコリネバク
テリウム・グルタミクムATCC 13032を親株と
して変異誘導したものである。Y AJ 1247B (FERM- These strains are mutated from Brevibacterium lactofermentum^TCC 13869, Brevibacterium flavum ATCC 14067, and Corynebacterium glutamicum ATCC 13032, respectively, using parent strains.
上記変異株の変異誘導方法としては、紫外線照射、放射
線照射変異誘導起剤処理等の通常の方法が用いられ、例
えば2000μg/n+j!のニトロソグアニジンでO
℃20分間処理する方法等がある.上記例示の菌株の各
薬剤耐性に関する実験結果を第1表に示す.
これらの菌株を用いてL−グルタミン酸を生産するには
次のような方法が用いられる.培地としては、甘蔗、甜
菜からの糖汁あるいは廃I!密、澱粉質原料加水分解物
質等のI!質原料、酢酸、エチルアルコール、パラフィ
ン等の非糖質原料を含有する液体培地を用い、培養を行
う。窒素源としては通常のL−グルタミン酸発酵に用い
られるアンモニウム塩、アンモニア水、尿素の他CSL
,蛋白質分解アミノ酸等が用いられる.その他、リン酸
塩、マグネシウム塩等の無機塩、サイアミン、ビオチン
等の微量栄養素等が適宜使用される。ま地に添加される
.培養は好気的条件下で行うのがよく、培養温度は24
〜37℃培養中pHは6〜9に制御するのがよ<pHの
調整には無機あるいは有機の酸性あるいはアルカリ性物
質、さらには尿素炭酸カルシウム、アンモニアガス等を
使用することが出来る。発酵液からのL−グルタξン酸
の採取はイオン交換樹脂法、その他の公知の方法を組合
せることにより行われる。As a method for inducing mutations in the above-mentioned mutant strain, conventional methods such as ultraviolet irradiation, radiation irradiation, and treatment with mutagenic agents are used. For example, 2000 μg/n+j! O with nitrosoguanidine
There are methods such as processing at ℃ for 20 minutes. Table 1 shows the experimental results regarding the drug resistance of the above-mentioned exemplified bacterial strains. The following method is used to produce L-glutamic acid using these strains. As a medium, sugar juice from cane, sugar beet or waste I! Dense, starchy raw material hydrolyzed substances, etc. I! Culture is performed using a liquid medium containing non-carbohydrate raw materials such as raw materials, acetic acid, ethyl alcohol, and paraffin. Nitrogen sources include ammonium salts, aqueous ammonia, urea, and CSL used in normal L-glutamic acid fermentation.
, proteolytic amino acids, etc. are used. In addition, inorganic salts such as phosphates and magnesium salts, micronutrients such as thiamine and biotin, etc. are used as appropriate. It is added to the soil. Cultivation is best carried out under aerobic conditions, with a culture temperature of 24°C.
During cultivation at ~37°C, the pH should be controlled at 6-9.To adjust the pH, inorganic or organic acidic or alkaline substances, as well as urea calcium carbonate, ammonia gas, etc. can be used. Collection of L-glutamic acid from the fermentation liquor is carried out by a combination of the ion exchange resin method and other known methods.
第1表の各菌株の生育度は次のようにして検定した.グ
ルコース0.5g/a、尿素0.15g/設、硫安0.
1 5 g / a, KHzPO*0. 3 g
/ +I4−κ2肝04Q,Ig/dl, MgSO
,・711!0 0.01g/d1、CaC 1 z
・2Hg0 0.’ 1 rrg/ a、サイアよ
ン塩酸塩10r/dl、ビオチン3 r / dl ,
NazB407 ’ 10ftg00.44trz/
a、FeC l t ・6H20 4. 8 5 m
g/ ilJ、CLISO4 ・5Hi0 1.9 5
mg/ dl、(NI44) tMQ1ozm ・41
1200. 1 8 5+ngldl、ZnSO4 ・
7H20 4 4 nv/dI,MnCl14Ht0
0.3611W/d1および表ニ示tffi〕プル
マイシンを含みpH7.0に調整した培地に、天然培地
(ペプトン1g/dI、酵母エキスIg/〃、NaCj
! 0.5g/dJ、pl1 7. 0 >スラント
で24時間培養した菌を無菌水で懸濁して接種し、24
時間培養して生育値を懸濁で測定した。The growth rate of each strain in Table 1 was tested as follows. Glucose 0.5g/a, urea 0.15g/a, ammonium sulfate 0.
15 g/a, KHzPO*0. 3g
/ +I4-κ2 liver 04Q, Ig/dl, MgSO
,・711!0 0.01g/d1, CaC 1 z
・2Hg0 0. ' 1 rrg/a, Siayone Hydrochloride 10 r/dl, Biotin 3 r/dl,
NazB407' 10ftg00.44trz/
a, FeCl t ・6H20 4. 8 5 m
g/ilJ, CLISO4 ・5Hi0 1.9 5
mg/dl, (NI44) tMQ1ozm ・41
1200. 1 8 5+ngldl, ZnSO4 ・
7H20 4 4 nv/dI, MnCl14Ht0
0.3611W/d1 and the indicated tffi] A natural medium (peptone 1g/dI, yeast extract Ig/〃, NaCj) was added to a medium containing purmycin and adjusted to pH 7.0.
! 0.5g/dJ, pl1 7. 0 > Bacteria cultured in a slant for 24 hours were suspended in sterile water and inoculated.
After culturing for hours, growth values were measured in suspension.
4.実施例−1
グルコース1 0 g /dl, KHZPO4 0
. 1 g /J、MgSO4・7FlzO o.
1 g /dl,サイアミン塩酸塩20r/d1、大豆
分解濃縮液(T − Nとして)36mg/dl、硫安
2.0g/d1、FeSOn’7H20 1vw/d
l、MnSO4・4Hz0 1mg/d!およびビオ
チン3 r/1 (pH7.0)の組成を有する培地
を調整し、その20mjiづつを500ml容振盪フラ
スコに入れ115゜Cで10分間加熱殺菌した。この培
地にそれぞれの菌を接種し往復振盪培養機により31.
5℃で培養を行った。4. Example-1 Glucose 10 g/dl, KHZPO4 0
.. 1 g/J, MgSO4.7FlzO o.
1 g/dl, thiamine hydrochloride 20r/d1, soybean decomposition concentrate (as T-N) 36mg/dl, ammonium sulfate 2.0g/d1, FeSOn'7H20 1vw/d
l, MnSO4・4Hz0 1mg/d! A medium having a composition of 3 r/1 and biotin 3 r/1 (pH 7.0) was prepared, and 20 mji of each was placed in a 500 ml shake flask and sterilized by heating at 115°C for 10 minutes. 31. Inoculate each bacteria into this medium and use a reciprocating shaking culture machine.
Culture was performed at 5°C.
なお、培養中は培養液をPH6.5〜8. 0に保つた
め、5g/d!の炭酸カルシウムを添加した.また24
時間目に2.5g/dlの硫安を添加し46時間で発酵
終了し、発酵液中に蓄積したし−グルタミン酸の対糖収
率を求めた。During cultivation, the culture solution should be kept at pH 6.5-8. 5g/d to keep it at 0! of calcium carbonate was added. 24 again
2.5 g/dl of ammonium sulfate was added at 46 hours, and the fermentation was completed in 46 hours, and the yield of glutamic acid accumulated in the fermentation liquid relative to sugar was determined.
結果を第2表に示す。The results are shown in Table 2.
第
2
表
実施例−2
ビートモラセスを還元糖として100■/値、KH.P
O4 1■/dI(pH7.0)の組成を有する培地
を調整し、その30mlづつを50On!!容振盪フラ
スコに分注し、115℃で10分加熱殺菌した.この培
地にそれぞれの菌を接種し、往復振盪培養機により31
.5℃で培養を行った。なお培養中は培養液をpH6.
5〜8.0に保つため400■/〃の尿素水を適宜添加
した。菌接種後所定の生育に到達時にポリオキシソルビ
クンモノパル主ナイトを4■/+++j!の濃度になる
よう添加して30時間で発酵を終了し、発酵液中に蓄積
したL−グルタξン酸の対糖収率を求めた。Table 2 Example-2 Beet molasses was used as reducing sugar at 100 μ/value, KH. P
Prepare a medium with a composition of O4 1■/dI (pH 7.0), and add 30 ml of it to 50 On! ! The mixture was dispensed into shaker flasks and sterilized by heating at 115°C for 10 minutes. Each bacteria was inoculated into this medium, and the culture medium was incubated with a reciprocating shaking culture machine for 31 days.
.. Culture was performed at 5°C. During cultivation, the culture solution should be kept at pH 6.
In order to maintain the temperature between 5 and 8.0, 400 μ/〃 of urea water was added as appropriate. When the specified growth is reached after inoculating the bacteria, add 4■/+++j of polyoxysorbicne monopal main night! The fermentation was completed in 30 hours, and the yield of L-glutanic acid accumulated in the fermentation liquid relative to sugar was determined.
結果を第3表に示す。The results are shown in Table 3.
第 3 表Table 3
Claims (1)
属し、プルマイシン、およびその誘導体に耐性を有し、
L−グルタミン酸生産能を有する微生物を培養し、培養
液中に生成蓄積したL−グルタミン酸を採取することを
特徴とするL−グルタミン酸の製造法。It belongs to the genus Brevibacterium or Corynebacterium and is resistant to purmycin and its derivatives.
1. A method for producing L-glutamic acid, which comprises culturing a microorganism capable of producing L-glutamic acid and collecting L-glutamic acid produced and accumulated in the culture solution.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1186282A JP2817228B2 (en) | 1989-07-19 | 1989-07-19 | Method for producing L-glutamic acid |
AU58745/90A AU628598B2 (en) | 1989-07-19 | 1990-07-06 | Process for producing l-glutamic acid |
KR1019900010782A KR970009156B1 (en) | 1989-07-19 | 1990-07-16 | Method for preparing L-glutamic acid |
PE1990172305A PE33790A1 (en) | 1989-07-19 | 1990-07-17 | PROCEDURE TO PRODUCE L-GLUTAMIC ACID |
BR909003459A BR9003459A (en) | 1989-07-19 | 1990-07-17 | PROCESS FOR THE PRODUCTION OF L-GLUTAMIC ACID |
MYPI90001193A MY105945A (en) | 1989-07-19 | 1990-07-17 | Process for producing l-glutamic acid. |
FR9009249A FR2649993B1 (en) | 1989-07-19 | 1990-07-19 | PROCESS FOR THE MANUFACTURE OF L-GLUTAMIC ACID |
US07/830,530 US5272067A (en) | 1989-07-19 | 1992-02-04 | Process for producing L-glutamic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1186282A JP2817228B2 (en) | 1989-07-19 | 1989-07-19 | Method for producing L-glutamic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0349690A true JPH0349690A (en) | 1991-03-04 |
JP2817228B2 JP2817228B2 (en) | 1998-10-30 |
Family
ID=16185579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1186282A Expired - Lifetime JP2817228B2 (en) | 1989-07-19 | 1989-07-19 | Method for producing L-glutamic acid |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP2817228B2 (en) |
KR (1) | KR970009156B1 (en) |
AU (1) | AU628598B2 (en) |
BR (1) | BR9003459A (en) |
FR (1) | FR2649993B1 (en) |
MY (1) | MY105945A (en) |
PE (1) | PE33790A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110923275B (en) * | 2019-12-24 | 2024-01-12 | 内蒙古阜丰生物科技有限公司 | Glutamic acid fermentation and extraction process |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3096252A (en) * | 1960-04-23 | 1963-07-02 | Ajinomoto Kk | Process for producing l-glutamic acid |
-
1989
- 1989-07-19 JP JP1186282A patent/JP2817228B2/en not_active Expired - Lifetime
-
1990
- 1990-07-06 AU AU58745/90A patent/AU628598B2/en not_active Ceased
- 1990-07-16 KR KR1019900010782A patent/KR970009156B1/en not_active IP Right Cessation
- 1990-07-17 MY MYPI90001193A patent/MY105945A/en unknown
- 1990-07-17 BR BR909003459A patent/BR9003459A/en not_active Application Discontinuation
- 1990-07-17 PE PE1990172305A patent/PE33790A1/en not_active IP Right Cessation
- 1990-07-19 FR FR9009249A patent/FR2649993B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PE33790A1 (en) | 1991-01-16 |
AU5874590A (en) | 1991-03-28 |
JP2817228B2 (en) | 1998-10-30 |
AU628598B2 (en) | 1992-09-17 |
KR970009156B1 (en) | 1997-06-07 |
KR910003108A (en) | 1991-02-26 |
MY105945A (en) | 1995-02-28 |
FR2649993B1 (en) | 1993-10-01 |
FR2649993A1 (en) | 1991-01-25 |
BR9003459A (en) | 1991-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2817155B2 (en) | Production method of L-arginine by fermentation method | |
JPS6236676B2 (en) | ||
JPH02186994A (en) | Production of l-amino acid by fermentation | |
JP3008565B2 (en) | Method for producing L-glutamic acid by fermentation method | |
JPH06237779A (en) | Production of l-glutamic acid by fermentation method | |
JPS6321479B2 (en) | ||
JPS6115695A (en) | Preparation of l-isoleucine by fermentation method | |
JP2876739B2 (en) | Production method of L-lysine by fermentation method | |
JP3006929B2 (en) | Production method of L-valine by fermentation method | |
JPS6224074B2 (en) | ||
JP2578463B2 (en) | Production method of L-lysine by fermentation method | |
JPH0665314B2 (en) | Fermentation method for producing L-valine | |
JP2578474B2 (en) | Method for producing L-glutamic acid | |
JPH0349690A (en) | Preparation of l-glutamic acid | |
JPS6224075B2 (en) | ||
JPH0561914B2 (en) | ||
JP2995816B2 (en) | Production method of L-lysine by fermentation method | |
JPH027635B2 (en) | ||
JPH0594A (en) | Production of anthranilic acid by fermentation | |
JPS6324896A (en) | Production of l-glutamic acid by fermentation | |
JPH04166092A (en) | Production of l-lysine by fermentation | |
JPH029795B2 (en) | ||
JPH0211236B2 (en) | ||
JPH055476B2 (en) | ||
JPS60156399A (en) | Preparation of 5'-xanthylic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090821 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term |